\
&
Contact us
\
&
Contact us
The Digital Europe programme (DIGITAL) aims to support the digital transition in the EU by fostering the uptake of digital technologies by businesses, citizens and public administration and enhancing digital skills of the workforce. DIGITAL is structured around different special objectives.
marie.timmermann@fwo.be
+32 2 550 15 59
Find the contact info on the site of WEWIS
The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.
The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.
Digital, Industry & Space Digital Europe AI Continent Cybersecurity
Flanders is pursuing an active industry and export policy focused on defence innovation. With the Flemish Innovation and Industry Strategy for Security and Defence (VISD) and a new weapon trading decree, the government plans to help local companies market their technologies internationally. The European defence and security market is rapidly expan... read more
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
